Showing 141-150 of 354 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| S1P transport inhibitors for prevention of T1D | Rector & Visitors of the University of Virginia | Kevin Lynch | Cures | 01-October-2024 to 30-September-2026 | $520,627.00 |
| Polyclonal IgM and Its Fcµ Fragment: Preclinical Advances Toward Type 1 Diabetes Therapy | Rector & Visitors of the University of Virginia | Preeti Chhabra | Cures | 01-May-2026 to 30-April-2029 | $982,880.00 |
| ST2 Tregs in enhancing islet transplantation | Rector & Visitors of the University of Virginia | Rahul Sharma | Cures | 01-July-2025 to 30-June-2028 | $499,997.13 |
| Alternative Splicing as a Trigger for Initiation and Progression of Islet Autoimmunity | Rector & Visitors of the University of Virginia | Stephen Rich | Cures | 01-February-2026 to 31-January-2029 | $880,914.00 |
| Improving Genetic Risk Scores for Type 1 Diabetes in East Asian Populations | Rector & Visitors of the University of Virginia | Stephen Rich | Cures | 01-June-2026 to 31-May-2029 | $899,995.00 |
| Evaluation of a novel insulin sensitizer on glycemic control, insulin usage, and cardiovascular biomarkers in people with type 1 diabetes who use closed-loop automated insulin delivery | Rector & Visitors of the University of Virginia | William Horton | Improving Lives | 01-August-2025 to 31-July-2028 | $1,031,908.99 |
| Reducing Glycemic Variability to Improve Cardiovascular Health in Type 1 Diabetes | Rector & Visitors of the University of Virginia | William Horton | Improving Lives | 01-December-2022 to 30-June-2027 | $858,072.00 |
| Modeling immune-islet interactions in a vascularized T1D microphysiological system platform | Regents of the University of California at Irvine | Christopher Hughes | Cures | 01-October-2026 to 30-September-2027 | $300,000.00 |
| Advanced CGM analyses for longitudinal monitoring of early-stage Type 1 Diabetes | Regents of the University of Colorado | Andrea Steck | Cures | 01-October-2024 to 30-September-2027 | $900,000.00 |
| Improving Early Type 1 Diabetes Management Through Dual Glucose–Ketone Monitoring: Metabolic Characterization, Prediction of Progression, and Patient Experience | Regents of the University of Colorado | Brigitte Frohnert | Cures | 01-August-2026 to 31-July-2029 | $1,500,000.00 |